Plasma amyloid-β40 in relation to subclinical atherosclerosis and cardiovascular disease: A population-based study

Plasma amyloid-β40 in relation to subclinical atherosclerosis and cardiovascular disease: A population-based study

Background and aims: We aimed to determine associations of plasma amyloid-β40 (Aβ40) with subclinical atherosclerosis and risk of atherosclerotic cardiovascular disease (ASCVD) in the general population. Methods: Between 2002 and 2005, plasma Aβ40 was measured by single molecule array (SiMoA®) in 38...

Full description

Bibliographic Details
Main Authors: Bos, D. (Author), Franco, O.H (Author), Ghanbari, M. (Author), Hilal, S. (Author), Hofman, A. (Author), Ikram, M.A (Author), Ikram, M.K (Author), Kavousi, M. (Author), Koudstaal, P.J (Author), Leening, M.J.G (Author), the Heart Brain Connection Consortium (Author), Vernooij, M.W (Author), Wolters, F.J (Author)
Format: Article
Language:English
Published: Elsevier Ireland Ltd 2022
Subjects:
Amyloid
Atherosclerosis
Cardiovascular disease
Coronary heart disease
Stroke
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items